Lateral Deviation of the Eyes on Forced Lid Closure in Patients with Cerebral Lesions
Arch Neurol 48:310-311, Sullivan,H.C.,et al, 1991
Anterior Operculum Syndrome
Neurol 39:1169-1172, Mao,C.C.,et al, 1989
Association of Atrial Septal Aneurysm and Shunt Size with Stroke Recurrence and Benefit From Patent Foramen Ovale Closure
JAMA Neurol 79:1175-1179, Mas,J-L.,et al, 2022
Five-Year Outcomes of PFO Closure or Antiplatelet Therapy for Cryptogenic Stroke
NEJM 384:970-971, , 2021
Left Atrial Appendage Occlusion during Cardiac Surgery to Prevent Stroke
NEJM 384:2081-2091,2154, Whitlock, R.P.,et al, 2021
Immunocompetent Patient with Multiple Cranial Nerve Palsies, Ataxia, and Cognitive Decline
Neurol 94:e225-e229, Nigam, M.,et al, 2020
Practice Advisory Update Summary: Patent Foramen Ovale and Secondary Stroke Prevention
Neurol 94:876-885, Messe, S.R.,et al, 2020
Evidence-Based Management of Patent Foramen Ovale in Patients with Ischemic Stroke
JAMA Neurol 75:147-148, Kamel, H., 2018
PFO Closure for Cryptogenic Stroke
NEJM 378:1639-1642, Mi, M.Y.,et al, 2018
Patent Foramen Ovale Closure, Antiplatelet Therapy or Anticoagulation Therapy Alone for Management of Cryptogenic Stroke?
BMJ 362:k2515, Kuijpers, T.,et al, 2018
Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke
NEJM 377:1022-1032,1006,1093, Saver, J.L.,et al, 2017
Patent Foramen Ovale Closure or Anticoagulation Vs. Antiplatelets after Stroke
NEJM 377:1011-1021,1006,1093, Mas, J.L,et al, 2017
Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy
Stroke 47:e190-e192, Stoker, T.B.,et al, 2016
Left Atrial Appendage Function and Stroke Risk
Stroke 46:3554-3559, Yaghi, S.,et al, 2015
Percutaneous Left Atrial Appendage Closure:Technical Aspects and Prevention of Periprocedural Complications with the Watchman Device
Workd J Cardiol 26:65-75, Mobius-Winkler,S.,et al, 2015
Clinicopathologic Conference, Lemierres Syndrome
NEJM 371:2018-2027, Case Record 36-2014, 2014
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
NEJM 368:1092-1100,1152, Carroll, J.D.,et al, 2013
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
NEJM 368:1083-1091,1152, Meier, B.,et al, 2013
Patent Foramen Ovale and Cryptogenic Stroke
Stroke 44:2676-2678, Furlan, A.J. and Jauss, M., 2013
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
NEJM 366:991-999,1048, Furlan,A.J.,et al, 2012
Critique of Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Stroke 43:3147-3149, Thaler, D.E.,et al, 2012
A New Landscape for Stroke Prevention in Atrial Fibrillation
Stroke 42:3316-3322, Banerjee, A.,et al, 2011
Closure of Patent Foramen Ovale After Cryptogenic Stroke
Lancet 368:350-352, Wrle,J., 2006
Embolic Stroke Due to a Left Atrial Thrombus Two Years After Placement of an Atrial Septal Defect Closure Device
Am J Cardiol 98:1294-1296, Raghu,A.,et al, 2006
Patent Foramen Ovale Closure Devices
JAMA 294:366-369, Maisel,W.H.&Laskey,W.K., 2005
Patent Foramen Ovale in Young Adults with Unexplained Stroke
NEJM 353:2361-2372, Kizer,J.R. &Devereux,R.B., 2005
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: No
Stroke 35:804-805,806, Tong,D.C. &Becker,K.J., 2004
Patent Foramen Ovale and Recurrent Stroke: Closure is the Best Option: Yes
Stroke 35:803-804,806, Furlan,A.J., 2004
Practice Parameter: Recurrent Stroke with Patent Foramen Ovale and Atrial Septal Aneurysm
Neurol 62:1042-1050, Messe,S.R.,et al, 2004
Does Transcatheter Closure of Patent Foramen Ovale Really "Shut the Door?"
Stroek 35:2140, Anzola,G.P.,et al, 2004
Should Thrombolysis be Given to a Stroke Patient Refusing Therapy Due to Profound Anosognosia?
Neurol 63:2440, Katz,J.M. &Segal,A.Z., 2004
Ptosis in Patients with Hemispheric Strokes
Neurol 58:620-624, Averbuch-Heller,L.,et al, 2002
Closure of Patent Foramen Ovale for Pardoxical Emboli: Intermediate-Term Risk of Recurrent Neurological Events Following Transcatheter Device Placement
J Am Coll Cardiol 35:1311-1316, Hung,J.,et al, 2000
Subjective Experience and Behavior in Acute Stroke,The Lausanne Emotion in Acute Stroke Study
Neurol 52:22-28, Ghika-Schmid,F.,et al, 1999
Pontine Anosognosia for Hemiplegia
Neurol 53:647-649, Evyapan,D.&Kumral,E., 1999
Localization of Lesion in Denial of Hemiplegia After Acute Stroke
Stroke 28:67-71, Ellis,S.&Small,M., 1997
Subjective Experiences of 24 Patients Dramatically Recovering from Stroke
Stroke 26:1285-1288, Grotta,J.&Bratina,P., 1995
Denial of Eye Closure in Acute Stroke
Stroke 25:1958-1962, Ellis,S.J.&Small,M., 1994
Denial of Illness in Stroke
Stroke 24:757-759, Ellis,S.J.&Small,M., 1993
Anosognosia in Patients with Cerebrovascular Lesions, A Study of Causative Factors
Stroke 23:1446-1453, Starkstein,S.E.,et al, 1992
The Pretectal Syndrome:206 Patients
Neurol 40:684-690, Keane,J.R., 1990
Apraxia of Eyelid Opening Secondary to Right Hemisphere Infarction
Ann Neurol 25:622-624, Kohnston,J.C.,et al, 1989
Septic Thrombosis of the Cavernous Sinuses
Arch Neurol 45:567-572, DiNubile,M.J., 1988
Lid Abnormalities Secondary to Cerebral Hemisphere Lesions
Ann Neurol 1:149, Nutt,J.G., 1977
Motivational & Structural Factors in the Denial of Hemiplegia
Arch Neurol 3:306-318, Ullman,M.,et al, 1960